药代-话题@MedSci

#药代#

158篇内容 | 1789人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1666715, encodeId=19fc1666e1591, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=2019年医药代表要大裁员？, objectType=article, longId=156107, objectId=8efb15610e1f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8efb15610e1f, replyNumber=0, likeNumber=37, createdTime=2019-08-10, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8efb15610e1f, moduleTitle=2019年医药代表要大裁员？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8efb15610e1f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666714, encodeId=aa441666e1419, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=最后一个月了医药代表应该控货吗？, objectType=article, longId=156015, objectId=933215601589, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=933215601589, replyNumber=0, likeNumber=29, createdTime=2019-01-17, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=933215601589, moduleTitle=最后一个月了医药代表应该控货吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=933215601589)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666717, encodeId=21291666e1709, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=荐读｜扑尔敏原料药企业实施垄断行为被处罚1243万元！医药代表备案制来了！, objectType=article, longId=157344, objectId=e60b15e34438, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e60b15e34438, replyNumber=0, likeNumber=25, createdTime=2019-08-16, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e60b15e34438, moduleTitle=荐读｜扑尔敏原料药企业实施垄断行为被处罚1243万元！医药代表备案制来了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e60b15e34438)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666724, encodeId=791c1666e2444, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=尼古丁和烟草研究协会（SRNT）年会：I / II期试验阐明了Cytisinicline的多剂量、药代动力学和药效学特征, objectType=article, longId=161124, objectId=282916112457, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=282916112457, replyNumber=0, likeNumber=40, createdTime=2019-09-29, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=282916112457, moduleTitle=尼古丁和烟草研究协会（SRNT）年会：I / II期试验阐明了Cytisinicline的多剂量、药代动力学和药效学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=282916112457)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666702, encodeId=350c1666e02a9, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=三甲医院：严限药代拜访，违者现场执法, objectType=article, longId=146576, objectId=1f131465e6ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f131465e6ed, replyNumber=0, likeNumber=32, createdTime=2019-02-27, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f131465e6ed, moduleTitle=三甲医院：严限药代拜访，违者现场执法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f131465e6ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666719, encodeId=7c721666e199c, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=多重政策冲击！药代得转型, objectType=article, longId=159894, objectId=63fb1598941b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63fb1598941b, replyNumber=0, likeNumber=40, createdTime=2019-08-29, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63fb1598941b, moduleTitle=多重政策冲击！药代得转型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63fb1598941b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666707, encodeId=49541666e0731, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=Ra Pharma宣布Zilucoplan在肾功能不全患者中的药代动力学结果, objectType=article, longId=149962, objectId=b17c149962ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b17c149962ab, replyNumber=0, likeNumber=23, createdTime=2019-06-10, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b17c149962ab, moduleTitle=Ra Pharma宣布Zilucoplan在肾功能不全患者中的药代动力学结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b17c149962ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666704, encodeId=6e8d1666e0435, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=九部委发文，影响所有医药人！药代备案马上实施..., objectType=article, longId=147371, objectId=fbb014e371d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbb014e371d5, replyNumber=0, likeNumber=37, createdTime=2019-02-14, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbb014e371d5, moduleTitle=九部委发文，影响所有医药人！药代备案马上实施..., moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbb014e371d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666705, encodeId=ec801666e05d0, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=三甲医院发通知，药代必须持证上岗, objectType=article, longId=148508, objectId=87771485087a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87771485087a, replyNumber=0, likeNumber=36, createdTime=2019-01-30, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87771485087a, moduleTitle=三甲医院发通知，药代必须持证上岗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87771485087a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666699, encodeId=69a9166669999, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=大批医药代表，正在离开行业, objectType=article, longId=141655, objectId=0dcb14165586, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0dcb14165586, replyNumber=0, likeNumber=29, createdTime=2018-07-15, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0dcb14165586, moduleTitle=大批医药代表，正在离开行业, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0dcb14165586)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666727, encodeId=af9f1666e2721, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=刚刚！大批药代，被解散, objectType=article, longId=162755, objectId=a61b162e5528, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a61b162e5528, replyNumber=0, likeNumber=20, createdTime=2019-11-18, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a61b162e5528, moduleTitle=刚刚！大批药代，被解散, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a61b162e5528)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666693, encodeId=7bca166669377, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=刚刚，多地药代被查被限, objectType=article, longId=139574, objectId=4bf31395e44c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bf31395e44c, replyNumber=0, likeNumber=21, createdTime=2019-04-19, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bf31395e44c, moduleTitle=刚刚，多地药代被查被限, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bf31395e44c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666721, encodeId=51181666e2128, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=药品带量采购试点开启：医药代表将迎大洗牌？, objectType=article, longId=160741, objectId=adf4160e41cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=adf4160e41cd, replyNumber=0, likeNumber=21, createdTime=2019-08-08, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adf4160e41cd, moduleTitle=药品带量采购试点开启：医药代表将迎大洗牌？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=adf4160e41cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666689, encodeId=e6b616666898a, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=8大危机，干掉大批药企、药代, objectType=article, longId=137498, objectId=243313e49831, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=243313e49831, replyNumber=0, likeNumber=36, createdTime=2018-09-22, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=243313e49831, moduleTitle=8大危机，干掉大批药企、药代, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=243313e49831)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666692, encodeId=f3561666692bb, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=黑名单来了！300万医药代表面临生死挑战, objectType=article, longId=139093, objectId=3e9413909363, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e9413909363, replyNumber=0, likeNumber=44, createdTime=2019-03-20, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e9413909363, moduleTitle=黑名单来了！300万医药代表面临生死挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e9413909363)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666698, encodeId=46c316666989c, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=抗菌药物药代动力学/药效学理论临床应用专家共识, objectType=article, longId=141580, objectId=c267141580eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c267141580eb, replyNumber=0, likeNumber=7, createdTime=2019-02-05, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c267141580eb, moduleTitle=抗菌药物药代动力学/药效学理论临床应用专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c267141580eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666712, encodeId=498f1666e1248, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=4 +7后大淘汰？药代反击了, objectType=article, longId=155518, objectId=5e6e155518d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e6e155518d6, replyNumber=0, likeNumber=31, createdTime=2019-07-12, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e6e155518d6, moduleTitle=4 +7后大淘汰？药代反击了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e6e155518d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666718, encodeId=ded91666e1829, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=60%老医药代表，已转行, objectType=article, longId=158095, objectId=5c35158095dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c35158095dd, replyNumber=0, likeNumber=28, createdTime=2019-10-06, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c35158095dd, moduleTitle=60%老医药代表，已转行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c35158095dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666700, encodeId=85aa1666e00d8, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=仿制药大潮来临医药代表未来在哪里, objectType=article, longId=142942, objectId=f6ff142942b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6ff142942b8, replyNumber=0, likeNumber=31, createdTime=2018-10-14, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6ff142942b8, moduleTitle=仿制药大潮来临医药代表未来在哪里, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6ff142942b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666695, encodeId=84f316666952a, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=力度空前！北京发文：严禁药代进门诊，清查院边药店, objectType=article, longId=140228, objectId=79bd140228c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79bd140228c2, replyNumber=0, likeNumber=25, createdTime=2018-10-18, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79bd140228c2, moduleTitle=力度空前！北京发文：严禁药代进门诊，清查院边药店, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79bd140228c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

药代

2020-05-29

fengyqf (审核中...)

前往app查看评论内容

#药代#

2019年医药代表要大裁员？

2019-08-10

fengyqf (审核中...)

前往app查看评论内容

#药代#

最后一个月了医药代表应该控货吗？

2019-01-17

fengyqf (审核中...)

前往app查看评论内容

#药代#

荐读｜扑尔敏原料药企业实施垄断行为被处罚1243万元！医药代表备案制来了！

2019-08-16

fengyqf (审核中...)

前往app查看评论内容

#药代#

尼古丁和烟草研究协会（SRNT）年会：I / II期试验阐明了Cytisinicline的多剂量、药代动力学和药效学特征

2019-09-29

fengyqf (审核中...)

前往app查看评论内容

#药代#

三甲医院：严限药代拜访，违者现场执法

2019-02-27

fengyqf (审核中...)

前往app查看评论内容

#药代#

多重政策冲击！药代得转型

2019-08-29

fengyqf (审核中...)

前往app查看评论内容

#药代#

Ra Pharma宣布Zilucoplan在肾功能不全患者中的药代动力学结果

2019-06-10

fengyqf (审核中...)

前往app查看评论内容

#药代#

九部委发文，影响所有医药人！药代备案马上实施...

2019-02-14

fengyqf (审核中...)

前往app查看评论内容

#药代#

三甲医院发通知，药代必须持证上岗

2019-01-30

fengyqf (审核中...)

前往app查看评论内容

#药代#

大批医药代表，正在离开行业

2018-07-15

fengyqf (审核中...)

前往app查看评论内容

#药代#

刚刚！大批药代，被解散

2019-11-18

fengyqf (审核中...)

前往app查看评论内容

#药代#

刚刚，多地药代被查被限

2019-04-19

fengyqf (审核中...)

前往app查看评论内容

#药代#

药品带量采购试点开启：医药代表将迎大洗牌？

2019-08-08

fengyqf (审核中...)

前往app查看评论内容

#药代#

8大危机，干掉大批药企、药代

2018-09-22

fengyqf (审核中...)

前往app查看评论内容

#药代#

黑名单来了！300万医药代表面临生死挑战

2019-03-20

fengyqf (审核中...)

前往app查看评论内容

#药代#

抗菌药物药代动力学/药效学理论临床应用专家共识

2019-02-05

fengyqf (审核中...)

前往app查看评论内容

#药代#

4 +7后大淘汰？药代反击了

2019-07-12

fengyqf (审核中...)

前往app查看评论内容

#药代#

60%老医药代表，已转行

2019-10-06

fengyqf (审核中...)

前往app查看评论内容

#药代#

仿制药大潮来临医药代表未来在哪里

2018-10-14

fengyqf (审核中...)

前往app查看评论内容

#药代#

力度空前！北京发文：严禁药代进门诊，清查院边药店

2018-10-18

科室
- - 订阅+
  - 更多科室
工具
服务